Table 5.

The contents (μg·g⁻¹) of six targets in nine commercial samples (n = 3).

	Analytes/Contents (μg·g−1)
Samples	MA	AC	HA	BMA	BAC	BHA
S-01	0.31 ± 0.01	7.55 ± 0.16	8.05 ± 0.10	295.20 ± 6.20	88.37 ± 2.16	45.45 ± 0.55
S-02	N.D. a	0.18 ± 0.003	0.67 ± 0.01	327.18 ± 7.71	62.10 ± 0.53	54.75 ± 2.03
S-03	0.60 ± 0.02	0.78 ± 0.01	5.22 ± 0.12	343.38 ± 1.03	27.46 ± 0.21	52.02 ± 0.23
S-04	0.02 ± 0.002	0.07 ± 0.01	0.13 ± 0.01	28.52 ± 2.32	3.57 ± 0.29	3.11 ± 0.24
S-05	0.24 ± 0.004	2.15 ± 0.02	2.16 ± 0.02	55.71 ± 0.82	11.12 ± 0.13	9.49 ± 0.01
S-06	0.11 ± 0.003	0.13 ± 0.01	0.35 ± 0.01	14.71 ± 0.80	1.28 ± 0.05	1.34 ± 0.08
S-07	0.18 ± 0.003	0.80 ± 0.004	0.96 ± 0.01	117.80 ± 8.21	13.31 ± 1.09	11.61 ± 0.60
S-08	0.19 ± 0.002	0.84 ± 0.01	0.70 ± 0.01	137.56 ± 4.35	16.47 ± 0.40	14.34 ± 0.44
S-09	0.19 ± 0.002	0.83 ± 0.01	0.99 ± 0.01	129.54 ± 1.43	15.33 ± 0.01	13.36 ± 0.01

^a N.D.: higher than LLOD and less than LLOQ.